Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

an class="prnews_span">(166)Deferred revenue 

7,636(2,818)Other liabilities 

(6,557)(1,223)Net cash used in operating activities 

(71,375)(72,448)Cash flows from investing activities:Maturities of investments 

118,777200,477Purchases of investments 

(166,496)(109,400)Purchases of property and equipment 

(5,192)(794)Net cash (used in) provided by investing activities 

(52,911)90,283Cash flows from financing activities:Payment of capital lease obligations 

(1,650)(1,466)Repayment of proceeds from sale of future royalties

(7,000)(3,000)Issuance of common stock, net of issuance costs

116,601-Proceeds from shares issued under equity compensation plans

7,9612,621Net cash provided by (used in) financing activities 

115,912(1,845)Effect of exchange rates on cash and cash equivalents 

65Net (decrease) increase in cash and cash equivalents 

(8,368)15,995Cash and cash equivalents at beg
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014 AVACEN Medical announced today ... 510 (k) OTC clearance by the U.S. Food and ... be marketed over the Internet for: the temporary ... and minor strains and sprains . Logo ... 100 (MSRP $2495) is a sophisticated medical device incorporating ...
(Date:10/22/2014)... 2014  With a vision to ensure safety ... Global Pharmaceutical and Biotech manufacturer selects and implements ... solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... aggregated by the Xyntek and Antares solution is ...
(Date:10/22/2014)...  Early symptoms of diabetic eye and vision ... technology, coupled with yearly, comprehensive eye exams, are ... of eye diseases, including those associated with diabetes, ... untreated, these diseases can potentially lead to vision ... optometric researchers have deployed a new tool that ...
Breaking Medicine Technology:AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Xyntek and Antares Serialization Solution Protects Pets Too! 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... today, at the American Psychiatric Association Annual Meeting in ... Psychiatry at UCLA, and a Senior Medical Advisor to ... open-label clinical trial that studied the effects of eTNS™ ... an adjunct to pharmacotherapy.  Results from the 17-question Hamilton ...
... Inc. is pleased to announce that Bio AMD Limited, ... the "Company" OTCBB: BIAD.OB, OTCQB: BIAD) has submitted a ... Cartridge Test Cap ("Cap") component used in its Digital ... in pregnancy and ovulation testing applications, typically require a ...
Cached Medicine Technology:Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 2Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 3Bio-AMD, Inc.; Patent Application for Cartridge Test Cap 2Bio-AMD, Inc.; Patent Application for Cartridge Test Cap 3
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. ... cold sores -- herpes simplex -- might increase the risk ... In fact, being a carrier of certain antibodies to the ... found. "The identification of a treatable cause [herpes ... said lead researcher Dr. Hugo Lovheim, an associate professor in ...
(Date:10/25/2014)... Oct. 24, 2014 (HealthDay News) -- Researchers who ... their findings are cause for concern. The ... are raised for human consumption contribute to the ... according to background information from the study. ... sicken about 2 million people and kill about ...
(Date:10/25/2014)... FRIDAY, Oct. 23, 2014 (HealthDay News) -- Current ... many younger postmenopausal women at risk for osteoporosis-related ... want to prevent fractures, we need tools that ... osteoporotic injuries so that we can target these ... Carolyn Crandall, professor of medicine in the division ...
(Date:10/25/2014)... 2014 (HealthDay News) -- October,s shorter, darker days can ... disorder, according to an expert. People affected ... overly tired, lack motivation and even have trouble getting ... to suicide, said Dr. Angelos Halaris, a professor in ... University Chicago Stitch School of Medicine. "Seasonal affective ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 On Saturday, October ... its fourth annual family health and fitness fair ¡Vive tu ... physical activity and good nutrition for better health and wellness ... which is free and open to the public, will be ... Brownsville, from 9:00 am to 1:00 pm. , “¡Vive ...
Breaking Medicine News(10 mins):Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... partners improving the quality of patient ... care using Microsoft technology., ... Microsoft Corp. today announced the winners of the,11th annual MS-HUG ... have been awarded to healthcare organizations, software,vendors and system integrators ...
... Feb. 26 Hospira, Inc.,(NYSE: HSP ... today announced a,new national agreement with HealthTrust ... provide HealthTrust member organizations with,access, on a ... related sets and disposables, along with intravenous,(I.V.) ...
... 26 February. Speciality European Pharma (SEP) today announced ... to treat advanced and metastatic hormone responsive prostate cancer ... testosterone levels, thereby giving quick control of prostate cancer ... can choose to either keep the patient on Plenaxis® ...
... Dramatically Improves Protection and Availability of Critical Patient ... and Archiving, HOPKINTON, Mass., Feb. 26 ... in information infrastructure solutions, today announced,that Norton Healthcare, ... the top 100 integrated healthcare delivery systems in ...
... Calif., Feb. 26 HASP Online announces,JSABuilder ( ... for,conducting Job Safety Analysis (JSA)., JSA, also ... proven and effective,technique of identifying potential job hazards ... them. The Occupational Health and,Safety Administration (OSHA) recommend ...
... About Medicare, Health Insurance Options, KANSAS CITY, ... boomers turn 62 this year and begin claiming ... the National Association of Insurance,Commissioners (NAIC), many are ... Medicare eligibility., The NAIC,s national survey of ...
Cached Medicine News:Health News:Microsoft and Microsoft Healthcare Users Group Announce Winners of MS-HUG Healthcare Innovation Awards 2008 2Health News:Microsoft and Microsoft Healthcare Users Group Announce Winners of MS-HUG Healthcare Innovation Awards 2008 3Health News:Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment 2Health News:Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment 3Health News:Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure 2Health News:Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure 3Health News:Norton Healthcare Delivers Information to the Point-of-Care with EMC Information Infrastructure 4Health News:HASP Online Provides Free Job Safety Analysis Tool Available Online 2Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 2Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 3Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 4Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 5Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 6
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: